Category Archives: BioUtah News
Epitel Publication accepted for Special Edition of Frontiers Neurology
Epitel’s second publication has been accepted for publication in a special edition of Frontiers Neurology.
Intermountain Healthcare Launches New Outpatient Imaging Services Company
Intermountain Healthcare is launching Tellica Imaging, a subsidiary company which will open and operate stand-alone outpatient imaging centers at easy-to-access locations.
Foldax Completes Enrollment in Early Feasibility Study for TRIA Biopolymer Surgical Aortic Heart Valve
Foldax®, Inc. announced completion of enrollment in the U.S. early feasibility study of the TRIA™ surgical aortic heart valve.
IONIQ Sciences Announces Dr. Benjamin Haibe-Kains has joined its Scientific Advisory Committee
On September 27, 2021, IONIQ Sciences announced that Dr. Benjamin Haibe-Kains has joined its Scientific Advisory Committee.
Co-Diagnostics, Inc. Announces Corporate Rebranding Following Period of Transformative Growth and Expansion
Co-Diagnostics, Inc. announced that following its recent transformative growth, the Company is rebranding its image to better reflect its expanded scope, mission, and upcoming expansion into new diagnostics verticals.
BioUtah Proudly Presents Biosphere Magazine and the “Rise of BioHive”
Each year, BioUtah publishes a special Utah life sciences magazine, released with the September issue of Utah Business Magazine, Our 2021 issue is our biggest yet with a feature story on the “Rise of BioHive.” We’ve also given the magazine a new name – Biosphere – to match our efforts to boldly brand and build […]
Sera Prognostics Announces Publication of Health Economic Analysis Supporting PRETRM® Test-and-Treat Strategy to Improve Maternal and Infant Health
Publication illustrates clinical benefit of combining PreTRM® testing with evidence-based interventions to improve neonatal health and reduce total health costs Positive impact on preterm births, neonatal intensive care admissions, overall hospital length of stay and a net $54 million reduction in total costs in the analyzed population Salt Lake City – September 14, 2021 – […]
Co-Diagnostics, Inc. Logix Smart™ ABC Test Authorized for Use in Mexico
Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that its Logix Smart™ Influenza A/Influenza B/COVID-19 “ABC” Test has been approved for sale in Mexico by the Mexican Department of Epidemiology (“InDRE”) after InDRE successfully concluded an independent evaluation of the test’s sensitivity […]
Xenter, Backcountry, and Sera Prognostics Add New Senior Executives
This week Xenter, Backcountry, and Sera Prognostics announced changes to their executive teams. Here’s the deets: Xenter Salt Lake City, Utah-based Xenter, Inc. (XenterMD.com) has announced a new President of Xenter Medical Technologies (formerly Xenter Hospital Technologies) business unit. Mark Turco, MD, is highly qualified, coming from Sirtex Medical where he served as Executive Vice […]
Intermountain Healthcare and SCL Health Announce Intent to Merge
Intermountain Healthcare and SCL Health, two leading nonprofit healthcare organizations, have signed a Letter of Intent to merge and create a model health system that provides high-quality, accessible, and affordable healthcare to more patients and communities in Utah, Idaho, Nevada, Colorado, Montana, and Kansas. Upon completion of the merger, the combined system will employ more […]
Mount Sinai Initiates System-wide Scale-Up of Renalytix KidneyIntelX™ Enabled Health Care Model
Renalytix plc (NASDAQ: RNLX) (LSE: RENX) and the Mount Sinai Health System today announced scaled-up implementation of the KidneyIntelX™ early-stage risk assessment testing and care management program across primary care and specialty clinician networks under a real-world evidence development program for patients with diabetic kidney disease (DKD). KidneyIntelX enables a shift in focus from care […]
PhotoPharmics brings renowned experts in Parkinson’s disease and other neurodegenerative diseases to advisory board
Clinical-stage medical device maker PhotoPharmics today announced a Clinical & Scientific Advisory board (CSAB) comprised of six leading experts in Parkinson’s disease (PD) and other neurodegenerative diseases. The board’s aim is to provide clinical and scientific advice and direction to support the PhotoPharmics mission to “Improve the lives of people who suffer from neurodegenerative diseases.” […]
